145 related articles for article (PubMed ID: 25658164)
1. Letter to the editor: Thiazides are not inducers of PTH secretion: a comment on normocalcemic hyperparathyroidism.
Yacobi-Bach M; Serebro M; Greenman Y; Tordjman K; Stern N
J Clin Endocrinol Metab; 2015 Feb; 100(2):L27-8. PubMed ID: 25658164
[No Abstract] [Full Text] [Related]
2. Letter to the editor: Distinguishing typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia by using an index of urinary calcium.
Marx SJ
J Clin Endocrinol Metab; 2015 Feb; 100(2):L29-30. PubMed ID: 25658165
[No Abstract] [Full Text] [Related]
3. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
Eastell R; Brandi ML; Costa AG; D'Amour P; Shoback DM; Thakker RV
J Clin Endocrinol Metab; 2014 Oct; 99(10):3570-9. PubMed ID: 25162666
[TBL] [Abstract][Full Text] [Related]
4. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
Silverberg SJ; Clarke BL; Peacock M; Bandeira F; Boutroy S; Cusano NE; Dempster D; Lewiecki EM; Liu JM; Minisola S; Rejnmark L; Silva BC; Walker MD; Bilezikian JP
J Clin Endocrinol Metab; 2014 Oct; 99(10):3580-94. PubMed ID: 25162667
[TBL] [Abstract][Full Text] [Related]
5. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
Udelsman R; Åkerström G; Biagini C; Duh QY; Miccoli P; Niederle B; Tonelli F
J Clin Endocrinol Metab; 2014 Oct; 99(10):3595-606. PubMed ID: 25162669
[TBL] [Abstract][Full Text] [Related]
6. Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.
Marcocci C; Brandi ML; Scillitani A; Corbetta S; Faggiano A; Gianotti L; Migliaccio S; Minisola S
J Endocrinol Invest; 2015 May; 38(5):577-93. PubMed ID: 25820553
[No Abstract] [Full Text] [Related]
7. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.
Bilezikian JP; Brandi ML; Eastell R; Silverberg SJ; Udelsman R; Marcocci C; Potts JT
J Clin Endocrinol Metab; 2014 Oct; 99(10):3561-9. PubMed ID: 25162665
[TBL] [Abstract][Full Text] [Related]
8. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.
Marcocci C; Bollerslev J; Khan AA; Shoback DM
J Clin Endocrinol Metab; 2014 Oct; 99(10):3607-18. PubMed ID: 25162668
[TBL] [Abstract][Full Text] [Related]
9. Letter to the Editor: Could Low Phosphate Level Be the Reason for High Risk of Hypertension in Normocalcemic Primary Hyperparathyroidism?
Kizilgul M; Beketaev I; Dolapoglu A
J Clin Endocrinol Metab; 2015 Jun; 100(6):L39. PubMed ID: 26047076
[No Abstract] [Full Text] [Related]
10. [News in endocrinology: Management of asymptomatic primary hyperparathyroidism in 2014].
Köhler BB; Philippe J
Rev Med Suisse; 2015 Jan; 11(456-457):58-61. PubMed ID: 25799652
[TBL] [Abstract][Full Text] [Related]
11. [Normocalcemic primary hyperparathyroidism: a growing problem].
Martínez Díaz-Guerra G; Guadalix Iglesias S; Hawkins Carranza F
Med Clin (Barc); 2013 Aug; 141(3):125-9. PubMed ID: 23199831
[TBL] [Abstract][Full Text] [Related]
12. Quality assessment of clinical practice guidelines: who watches the watchmen?
Nagler EV; Ball S
Clin Endocrinol (Oxf); 2013 Feb; 78(2):181-2. PubMed ID: 22943208
[No Abstract] [Full Text] [Related]
13. [Symptomatic and asymptomatic primary hyperparathyroidism in outpatient care - current issues].
Šiprová H; Souček M; Fryšák Z; Šipr K
Vnitr Lek; 2016; 62(10):775-780. PubMed ID: 27900863
[TBL] [Abstract][Full Text] [Related]
14. [Primary hyperparathyroidism: new concepts, new recommendations].
Crouzeix G; Kerlan V
Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S21-36. PubMed ID: 25617920
[TBL] [Abstract][Full Text] [Related]
15. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
[TBL] [Abstract][Full Text] [Related]
16. Challenges in Developing Recommendations Based on Low-Quality Evidence in Thyroid Guidelines.
Sawka AM; Alexander EK; Bianco AC; Chou R; Haugen BR; Kopp PA; Pearce EN; Ross DS; Smallridge RC; Jonklaas J
Thyroid; 2021 Jan; 31(1):3-7. PubMed ID: 32900277
[No Abstract] [Full Text] [Related]
17. Clinical guidelines in diabetes.
Holt RIG
Diabet Med; 2018 Aug; 35(8):987. PubMed ID: 30152587
[No Abstract] [Full Text] [Related]
18. [Normocalcemic primary hyperparathyroidism: recommendations for management and follow-up].
Martínez Díaz-Guerra G; Jódar Gimeno E; Reyes García R; Gómez Sáez JM; Muñoz-Torres M;
Endocrinol Nutr; 2013 Oct; 60(8):456.e1-6. PubMed ID: 23660008
[TBL] [Abstract][Full Text] [Related]
19. [Asymptomatic primary hyperparathyroidism in women].
Spivacow FR; Palumbo C
Medicina (B Aires); 2017; 77(3):196-200. PubMed ID: 28643676
[TBL] [Abstract][Full Text] [Related]
20. An overview of normocalcemic primary hyperparathyroidism.
Pawlowska M; Cusano NE
Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):413-21. PubMed ID: 26512768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
